D-Wave Quantum: Nature Papers, CHIPS Act Equity, and a Stock That Won't Play Along

Commerce finalized $100M grants for D-Wave, Rigetti and Quantinuum, taking minority stakes tied to technical milestones.

Washington's habit of taking equity in the companies it funds has reached the quantum computing sector, and D-Wave Quantum is now firmly part of the experiment. The US Department of Commerce finalised grant awards on Tuesday for D-Wave, Rigetti Computing and Quantinuum — each worth up to USD 100 million, for a combined USD 300 million drawn from the CHIPS Act. In return, the government takes minority stakes in all three, with the bulk of the money tied to hitting concrete technical milestones rather than arriving as a lump sum.

The terms are identical across the trio, which matters: none of the three providers gains a structural edge over the others, and the race toward technological milestones and commercial applications stays wide open. Quantinuum, for its part, is putting its allocation toward a trapped-ion manufacturing build-out with GlobalFoundries and supplier Monarch Quantum, aiming to push two-qubit gate fidelity from today's 99.92 percent toward 99.999 percent.

A pattern that was set in May

For D-Wave, this is merely the latest chapter in a longer story of state intervention in quantum capital structures. Back in May, the Commerce Department signalled letters of intent covering more than USD 2 billion for nine quantum computing firms, again in exchange for minority holdings. The template is now well established: want government money, hand over a slice of the company.

The cost of that template lands on existing shareholders. Rigetti and D-Wave together issued close to 15 million new shares to bring the government in as a minority investor — dilution that got lost in the initial euphoria over the CHIPS Act headlines. Every newly minted share trims the relative claim of investors who were already on the register.

The science underneath the cheque

Strip away the politics and there is a research story that arguably carries more weight for D-Wave's actual business model. In early August, the company published peer-reviewed results in Nature describing a fast, high-precision two-qubit gate for its superconducting dual-rail architecture within the gate model. Fidelity came in at roughly 99.9 percent, with operation times of about 500 nanoseconds. Simulations suggest the dual-rail design could cut logical error rates by as much as a factor of ten with each error-correction step.

That work underpins a roadmap targeting a system with 100 logical qubits and more than one million operations by 2032 — not a marketing claim, but fundamental physics run through one of science's strictest peer-review processes. Three days before that publication, D-Wave had also announced a collaboration with Nasdaq Verafin to explore quantum computing for improving financial crime detection. Two announcements, one thread: the company is trying to stand simultaneously as a basic researcher and a commercial partner, a balancing act few in this young industry pursue as consistently.

Those two building blocks — the scientific paper and the commercial pilot — form the foundation beneath the more recent news. The CHIPS and Science Act money is meant to fund expansion of D-Wave's annealing and gate-model systems, including planned machines with 100,000 and 10,000 qubits respectively. The department receives a minority stake without control rights, and further tranches only flow once milestones in installation, manufacturing, process integration and calibration are met. State capital is thus wired directly to technical substance: without credible physics like the Nature results, there would be little justification for a government agency to take equity in a still-lossmaking company.

Ambition meets the income statement

Run the roadmap against the actual numbers and the picture grounds itself quickly. D-Wave booked USD 3.1 million in revenue in the second quarter, essentially flat year on year. Commercial customers accounted for 62.4 percent of that, and Forbes Global 2000 companies for 47.7 percent.

Bookings told a wilder story: up 59 percent in the quarter to USD 2.1 million, and up 1,120 percent across the first half to USD 35.5 million, driven by a single system sale worth more than USD 20 million. First-half revenue itself fell 67 percent to USD 5.9 million, since a large system sale from 2025 was missing from the comparative base. That gap between exploding bookings and shrinking recurring revenue captures the pattern across many quantum names: individual orders distort the statistics, and a dependable revenue stream has yet to appear.

What the tape says

The share price reflects the contradictions. After closing at EUR 14.73 on Wednesday, down 3.2 percent from the prior session, the stock sits more than 64 percent below its twelve-month high of EUR 40.41 reached on 15 October, yet still 32 percent above its 30 March low. Year to date it is down 35 percent; over twelve months it is up 7.4 percent — evidence of just how violent the ride is in this sector. The shares currently change hands at EUR 14.58, roughly 22 percent under their 200-day moving average of EUR 18.62, a sign that the medium-term downtrend remains intact despite the grant millions. Since the start of the year the stock has shed 36 percent, having traded at EUR 40.41 in October.

Analysts at Zacks Research downgraded the shares from "Strong Buy" to "Hold" on 21 August — a caution worth heeding given annualised volatility of 78 percent, without dismissing the technological substance.

The dilution from fresh share issuance is unlikely to reverse that trend on its own. The funding does give D-Wave fresh access to development capital, but the company pays a price beyond the milestone conditions: each new share erodes the relative stake of existing investors. For a business whose revenue recently sat in the low single-digit millions while its cash pile runs into the several hundreds of millions of dollars, the decisive question is whether the government's involvement genuinely accelerates the path to commercially viable quantum computers — or merely shifts the capital structure at the expense of legacy shareholders.

Political tailwinds for the industry show no sign of fading. The Pentagon and DARPA are running their own programmes to foster industrially usable quantum computers, with a horizon stretching to 2033. For D-Wave, that means state contracts and equity participations are likely to remain a fixed part of the business model for the foreseeable future — with all the opportunities and dilution risks that entails.

The real question is not whether D-Wave can publish in Nature or attract government money; both are documented facts. It is whether physical breakthroughs and pilot projects eventually become a revenue model that turns booking spikes into steady income. The earliest answer arrives with the next quarterly report on 2 November.